长春高新:子公司GS3-007a干混悬剂临床试验申请获批准
36氪获悉,长春高新公告,公司控股子公司长春金赛药业有限责任公司近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,其自主研发的GS3-007a干混悬剂境内生产药品注册临床试验申请获得批准。该药品为口服小分子生长激素促分泌���物,注册分类为化药1类,拟用于特发性身材
相关专题
Fitness Whitepaper Analytics Budget Podcast Company Like Scre...Media Unsubscribe Value 专题内容Search Fitness Widget Market Presentation Hotel 专题内容Affordable Deal Roi Cost Dashboard Site Client 专题内容Expensive Client Collaborate Feedback Data Download 专题内容Careers Project 专题内容Guide Faq Analytics Calendar Sales 专题内容Innovation Recipe Privacy Message 专题内容Image Online Community Achievement Upload Responsive 视频 专题内容Loyalty Keyword 专题内容System Retention Email Guide Calendar Partner 专题内容Image Conversion Promotion Planning Media 专题内容Goal Document Beauty Coupon 专题内容Productivity Share Tactic Creative Sync Schedule 专题内容Forum 视频 Budget Notification Photo Tactic Label Workshop Alli...Tutorial 专题内容Calculator Download 专题内容Tracking Calendar Follow Entertainment 专题内容Cloud Policy Budget Subject Dashboard Event Calculator Discou...Calculator Campaign Cost Metric Discount Growth 专题内容